interventional cardiology

Pre-Clinical Trial Results

Controlled and prolonged elution kinetics and efficient drug transfer to arteries.

MiStent's unique coating formulation and technology delivers a controlled and sustained release of a drug from a rapidly absorbing polymer. This differentiated method of target drug delivery has already shown promising results related to safety and prolonged elution kinetics in pre-clinical porcine trials.

Clinical significance in humans is unknown.

Caution: The Micell products described on this website are not available for sale or clinical use for any indications.

Home | About Us | Therapuetic Focus | Product Pipeline | Technology | News | Terms of Use | Privacy Policy | Site Map 2009 Micell Technologies, Inc.
All rights reserved